ResPECT-LM on MBCBrainMets.org

by | Jan 16, 2025 | LM

ReSPECT-LM Clinical Trial: Now Featured on MBCBrainMets.org! 📢 Exciting news! The ReSPECT-LM Clinical Trial is now a featured clinical trial on MBCBrainMets.org, a trusted resource hub for breast cancer patients living with brain metastases. 🔎 Learn more about the...

Did You Know: LM Fact

by | Jan 10, 2025 | LM

Did You Know? Leptomeningeal Metastases (LM) Rise From Various Cancers Leptomeningeal metastases (LM) is a serious condition where cancer cells spread to the leptomeninges, the membranes that cover the brain and spinal cord. While any cancer can metastasize to the...

ReSPECT-LM Locations

by | Jan 7, 2025 | LM

🚀 Plus Therapeutics Doubles ReSPECT-LM Clinical Trial Locations in 2024 Plus Therapeutics is proud to announce that we have doubled the number of locations for our ReSPECT-LM clinical trial in 2024, expanding to 6 investigation sites nationwide. This significant...

ReSPECT-LM at SABCS Presentation

by | Dec 17, 2024 | LM

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data at 2024 San Antonio Breast Cancer Symposium (SABCS) ICYMI: Plus Therapeutics presented our ReSPECT-LM Phase 1 interim data for Breast Cancer patients with Leptomeningeal Metastases at the 2024 San...

SABCS 2024 Booth

by | Dec 11, 2024 | LM

Reminder: Visit Plus Therapeutics at #SABCS2024 in San Antonio – Booth #1542! Join us at #SABCS2024 in San Antonio, Texas, where Plus Therapeutics will be showcasing its groundbreaking work in targeted radiation therapy for central nervous system cancers including...

WATCH NOW: Leptomeningeal Metastases SNO Symposium

by | Dec 9, 2024 | LM

⏯️ 🧠 Now Streaming: Replay the Live Symposium by Plus Therapeutics at #SNO2024 Annual Conference Catch up on the latest advancements in leptomeningeal disease and cancer therapeutics! The live symposium presented by Plus Therapeutics at the #SNO2024 Annual Meeting is...